| Pentixap. | 2,44 € | +1,24% | ||
| Sartorius. | 236,00 € | +0,13% | ||
| BB Biote. | 41,40 ¤ | 0,00% | ||
| Formyco. | 20,10 € | 0,00% | ||
| Sartorius. | 185,80 € | -1,06% | ||
| Evotec SE | 4,682 € | -1,43% | ||
| Heidelbe. | 2,56 € | -1,92% | ||
| 2Invest AG | 8,52 € | -2,96% | ||
| Medigen. | 0,0192 € | -4,95% | ||
| Paion AG | 0,064 € | -20,50% |
| CO.DON . | 0,0175 € | -22,22% | ||
| Paion AG | 0,064 € | -20,50% | ||
| Medigen. | 0,0192 € | -4,95% | ||
| 2Invest AG | 8,52 € | -2,96% | ||
| Heidelbe. | 2,56 € | -1,92% | ||
| Evotec SE | 4,682 € | -1,43% | ||
| Sartorius. | 185,80 € | -1,06% | ||
| BB Biote. | 41,40 ¤ | 0,00% | ||
| Formyco. | 20,10 € | 0,00% | ||
| Sartorius. | 236,00 € | +0,13% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Xetra | 495,39 | -1,03% | 500,56 | 09.06.26 | |
| Aktie | Marktkap. in Mio. € | Anzahl Jahre Outperformance | Performance Ø |
|---|---|---|---|
| Sartorius AG Vz | 8.080,33 | 7 | +22,72% |
| Heidelberg Pharma AG | 119,76 | 5 | +17,38% |
| Evotec SE | 1.657,43 | 5 | +17,33% |
| Datum | Kurs |
|---|---|
| 09.06.26 | 495,39 |
| 08.06.26 | 500,56 |
| 05.06.26 | 499,92 |
| 04.06.26 | 516,28 |
| 03.06.26 | 499,69 |
| Name | Letzter | Performance | |
|---|---|---|---|
| DAX | 24.260 | -0,71% | |
| Nasdaq 100 | 28.758 | -1,10% | |
| MDAX (Perf.) | 31.306 | -1,06% | |
| SDAX (Perf.) | 17.894 | -0,73% | |
| Dow Jones Industrial. | 50.542 | -0,66% | |
| S&P 500 | 7.331 | -0,68% | |
| ATX (Austrian Traded. | 5.961 | -0,79% | |
| MSCI World | 4.703 | -0,49% | |
| Euro Stoxx 50 | 6.019 | -0,50% | |
| MDAX (Kurs) | 14.980 | -1,50% |
| Wertpapier | Beiträge | Perf. |
| Evotec SE | 7 | - |
| Heidelberg Pharma AG | 2 | - |